Seres Therapeutics, Inc. Restricted Cash and Cash Equivalents, Noncurrent
Seres Therapeutics, Inc. (MCRB) had Restricted Cash and Cash Equivalents, Noncurrent of $113.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2019-03-06
- 2018-12-31: Restricted Cash and Cash Equivalents, Noncurrent $113.00K.
- 2018-06-30: Restricted Cash and Cash Equivalents, Noncurrent $1.51M.
- 2018-03-31: Restricted Cash and Cash Equivalents, Noncurrent $1.51M.
- 2017-12-31: Restricted Cash and Cash Equivalents, Noncurrent $113.00K; Restricted Cash and Cash Equivalents, Noncurrent as first filed $1.51M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent | Restricted Cash and Cash Equivalents, Noncurrent as first filed |
|---|---|---|
| 2018-12-31 | $113.00K 10-K · filed 2019-03-06 | |
| 2018-06-30 | $1.51M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $1.51M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $113.00K 10-K · filed 2019-03-06 | $1.51M 10-K · filed 2018-03-08 |
| 2017-09-30 | $1.51M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.51M 10-Q · filed 2018-08-02 | |
| 2017-03-31 | $1.40M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $1.40M 10-Q · filed 2018-08-02 | |
| 2016-09-30 | $1.42M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.54M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $1.54M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $1.54M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $139.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $139.00K 10-Q · filed 2015-08-10 | |
| 2014-12-31 | $139.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |